316 related articles for article (PubMed ID: 22770797)
1. Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling -- results of an international survey in 10 countries.
Gemzell-Danielsson K; Cho S; Inki P; Mansour D; Reid R; Bahamondes L
Contraception; 2012 Dec; 86(6):631-8. PubMed ID: 22770797
[TBL] [Abstract][Full Text] [Related]
2. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
3. General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK.
Middleton AJ; Naish J; Singer N
Eur J Contracept Reprod Health Care; 2011 Aug; 16(4):311-8. PubMed ID: 21585243
[TBL] [Abstract][Full Text] [Related]
4. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
Römer T; Linsberger D
Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
[TBL] [Abstract][Full Text] [Related]
5. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
[TBL] [Abstract][Full Text] [Related]
6. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
Hubacher D; Masaba R; Manduku CK; Veena V
Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
8. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
Wildemeersch D; Janssens D; Vrijens M; Weyers S
Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
[TBL] [Abstract][Full Text] [Related]
9. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
[TBL] [Abstract][Full Text] [Related]
10. Selection and performance of the levonorgestrel-releasing intrauterine system.
Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
Short M; Dallay D; Omokanye S; Hanisch JU; Inki P
Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):79-88. PubMed ID: 22200172
[TBL] [Abstract][Full Text] [Related]
12. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
13. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
Selim MF; Hussein AF
Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
[TBL] [Abstract][Full Text] [Related]
14. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
Jensen JT; Nelson AL; Costales AC
Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.
Bahamondes MV; Monteiro I; Castro S; Espejo-Arce X; Bahamondes L
Hum Reprod; 2010 May; 25(5):1158-64. PubMed ID: 20185512
[TBL] [Abstract][Full Text] [Related]
17. The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception.
Mansour D
Contraception; 2012 Mar; 85(3):224-34. PubMed ID: 22067761
[TBL] [Abstract][Full Text] [Related]
18. The levonorgestrel intrauterine system in nulliparous women.
Prager S; Darney PD
Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
[TBL] [Abstract][Full Text] [Related]
19. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
Li CF; Lee SS; Pun TC
Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
[TBL] [Abstract][Full Text] [Related]
20. Use of the levonorgestrel releasing-intrauterine system in nulliparous women--a non-interventional study in Sweden.
Marions L; Lövkvist L; Taube A; Johansson M; Dalvik H; Øverlie I
Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):126-34. PubMed ID: 21417562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]